Contingency management for patients receiving medication for opioid use disorder: a systematic review and meta-analysis

HA Bolívar, EM Klemperer, SRM Coleman… - JAMA …, 2021 - jamanetwork.com
Importance Medication treatment for opioid use disorder (MOUD) is efficacious, but
comorbid stimulant use and other behavioral health problems often undermine efficacy …

[HTML][HTML] Molecular genetics of cocaine use disorders in humans

N Fernandez-Castillo, J Cabana-Dominguez… - Molecular …, 2022 - nature.com
Drug addiction, one of the major health problems worldwide, is characterized by the loss of
control in drug intake, craving, and withdrawal. At the individual level, drugs of abuse …

Understanding stimulant use and use disorders in a new era

D Ciccarone, S Shoptaw - Medical Clinics, 2022 - medical.theclinics.com
The United States is in an era of unprecedented levels of drug-related mortality, evidenced
by an exponential increase in deaths over a recent 38-year period. 1 The recent drivers of …

The fourth wave of the overdose crisis: Examining the prominent role of psychomotor stimulants with and without fentanyl

RA Rawson, TG Erath, HW Clark - Preventive Medicine, 2023 - Elsevier
The current overdose and broader public health crisis involving illicit drug use is often
referred to as the “opioid” or “fentanyl” crisis. Clearly there is extensive data on the profound …

[HTML][HTML] Exploring protective associations between the use of classic psychedelics and cocaine use disorder: A population-based survey study

GM Jones, MK Nock - Scientific Reports, 2022 - nature.com
Abstract Cocaine Use Disorder (CUD) is a significant public health problem associated with
elevated morbidity and mortality within the United States. Current behavioral treatments …

Cocaine use disorder (CUD): current clinical perspectives

EKC Schwartz, NR Wolkowicz… - Substance Abuse and …, 2022 - Taylor & Francis
Cocaine use disorder (CUD) is a devastating disorder, impacting both individuals and
society. Individuals with CUD face many barriers in accessing treatment for CUD, and most …

Modifications to 1-(4-(2-Bis (4-fluorophenyl) methyl) sulfinyl) alkyl Alicyclic Amines That Improve Metabolic Stability and Retain an Atypical DAT Inhibitor Profile

AV Okorom, GA Camacho-Hernandez… - Journal of medicinal …, 2023 - ACS Publications
Atypical dopamine transporter (DAT) inhibitors have shown therapeutic potential in the
preclinical models of psychostimulant use disorders (PSUD). In rats, 1-(4-(2-((bis (4 …

Contingency management for stimulant use disorder: progress, challenges, and recommendations

RA Rawson, TG Erath, M Chalk, HW Clark… - The Journal of …, 2023 - journals.lww.com
Abstract The United States is currently in the fourth wave of the overdose crisis wherein
stimulants together with fentanyl are the major drivers of overdose deaths. To date, there has …

Contingency management plus acceptance and commitment therapy for initial cocaine abstinence: Results of a sequential multiple assignment randomized trial …

JM Schmitz, AL Stotts, AA Vujanovic, JH Yoon… - Drug and Alcohol …, 2024 - Elsevier
Background This study tested an adaptive intervention for optimizing abstinence outcomes
over phases of treatment for cocaine use disorder using a SMART design. Phase 1 …

[HTML][HTML] A scoping review of electroencephalographic (EEG) markers for tracking neurophysiological changes and predicting outcomes in substance use disorder …

TS Bel-Bahar, AA Khan, RB Shaik… - Frontiers in Human …, 2022 - frontiersin.org
Substance use disorders (SUDs) constitute a growing global health crisis, yet many
limitations and challenges exist in SUD treatment research, including the lack of objective …